| Title | Health Biotechnology and Biopharma |
| Type of Publication | Journal |
| Discipline | Biotechnology (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4) |
| Impact Score | 0.29 |
| SCImago Journal Rank (SJR) | 0.115 |
| h-index | 2 |
| Overall Rank | 24748 |
| Publisher Name | Health Biotechnology And Biopharma |
| Publication Country | Iran |
| International Standard Serial Number (ISSN) | 25384414 |
| Coverage and History | 2021-2022 |
| Best Quartile | Q4 |
| Total Citations Received (Last 3 Year) |
12 |
Health Biotechnology and Biopharma is a journal published by Health Biotechnology And Biopharma. This journal covers the area[s] related to Biotechnology, Pharmacology (medical), Pharmacology, Toxicology and Pharmaceutics (miscellaneous), etc.
The coverage history of this journal is as follows: 2021-2022.
The rank of this journal is 24748. This journal's impact score, h-index, and SJR are 0.29, 2, and 0.115, respectively. The ISSN of this journal is/are as follows: 25384414.
The best quartile of Health Biotechnology and Biopharma is Q4.
This journal has received a total of 12 citations during the last three years (Preceding 2022).
The latest impact score (IS) of the Health Biotechnology and Biopharma is 0.29. It is computed in the year 2023 as per its definition and based on Scopus data.
The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact Score 2022 of Health Biotechnology and Biopharma is 0.29. If a similar upward trend continues, IS may increase in 2023 as well.
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Coming Soon |
| 2022 | 0.29 |
| 2021 | 0.00 |
| 2020 | 0.00 |
The h-index of Health Biotechnology and Biopharma is 2. By definition of the h-index, this journal has at least 2 published articles with more than 2 citations.
The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.
The International Standard Serial Number (ISSN) of Health Biotechnology and Biopharma is/are as follows: 25384414.
The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.
ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC
Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}
The Health Biotechnology and Biopharma is ranked 24748 among 27955 Journals, Conferences, and Book Series.
As per SJR, this journal is ranked 0.115.
SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
The publisher of Health Biotechnology and Biopharma is Health Biotechnology And Biopharma. The publishing house of this journal is located in the Iran. Its coverage history is as follows: 2021-2022.
Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).
If your area of research or discipline is related to Biotechnology, Pharmacology (medical), Pharmacology, Toxicology and Pharmaceutics (miscellaneous), etc., please check the journal's official website to understand the complete publication process.
There are several factors that influence the acceptance rate of any academic journal. Here are some critical parameters that are considered while calculating the acceptance rate:
The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.
The latest impact score of Health Biotechnology and Biopharma is 0.29. It is computed in the year 2023.
The latest h-index of Health Biotechnology and Biopharma is 2. It is evaluated in the year 2023.
The latest SCImago Journal Rank (SJR) of Health Biotechnology and Biopharma is 0.115. It is calculated in the year 2023.
The latest ranking of Health Biotechnology and Biopharma is 24748. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.
Health Biotechnology and Biopharma is published by Health Biotechnology And Biopharma. The publication country of this journal is Iran.
This standard abbreviation of Health Biotechnology and Biopharma is .
Health Biotechnology and Biopharma is a journal published by Health Biotechnology And Biopharma.
The scope of Health Biotechnology and Biopharma is as follows:
For detailed scope of Health Biotechnology and Biopharma, check the official website of this journal.
The International Standard Serial Number (ISSN) of Health Biotechnology and Biopharma is/are as follows: 25384414.
The best quartile for Health Biotechnology and Biopharma is Q4.
The coverage history of Health Biotechnology and Biopharma is as follows 2021-2022.
Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
| Journal/Conference/Book Title | Type | Publisher | Ranking | SJR | h-index | Impact Score |
|---|---|---|---|---|---|---|
| European Union Politics | Journal | SAGE Publications Ltd | 2250 | 72 | 2.64 | |
| Materials Research | Journal | Universidade Federal de Sao Carlos | 14791 | 65 | 1.62 | |
| Transnational Corporations | Journal | UNCTAD United Nations Conference on Trade and Development | 6120 | 27 | 1.92 | |
| Studies in Continuing Education | Journal | Routledge | 6011 | 38 | 2.81 | |
| Sapporo Medical Journal | Journal | Cancer Research Institute, Sapporo Medical University | 20468 | 3 | 0.00 | |
| Rinsan Shikenj Oha/Journal of the Hokkaido Forest Products Research Institute | Journal | Hoikkaido Forest Products Research Institute | 25369 | 4 | 0.00 | |
| Current Protocols in Cell Biology | Journal | John Wiley & Sons Inc. | 3672 | 46 | 3.94 | |
| Society and Economy | Journal | Akademiai Kiado | 18366 | 15 | 0.93 | |
| Acta Colombiana de Psicologia | Journal | Universidad Catolica de Colombia | 18258 | 15 | 0.73 | |
| Journal of Tissue Engineering and Regenerative Medicine | Journal | John Wiley and Sons Ltd | 7762 | 85 | 3.55 |
| Year | Impact Score (IS) |
|---|---|
| 2023/2024 | Updated Soon |
| 2022 | 0.29 |
| 2021 | 0.00 |
| 2020 | 0.00 |
0.29
0.115
2
24748
